US Stock MarketDetailed Quotes

GBT Global Blood Therapeutics

Watchlist

0.000
0.0000.00%

Close Apr 24 09:30 ET

0Market Cap0.00P/E (TTM)

Global Blood Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

0.03%-44.31M

9.34%-71.85M

-21.22%-256.81M

-50.73%-67.93M

-60.49%-65.31M

6.66%-44.32M

-0.81%-79.26M

-8.97%-211.86M

27.71%-45.07M

24.40%-40.69M

Net income from continuing operations

-18.51%-82.47M

-8.67%-81.42M

-22.43%-303.09M

-41.70%-87.58M

-18.55%-70.99M

-31.70%-69.59M

-2.61%-74.93M

7.20%-247.55M

35.60%-61.81M

7.23%-59.88M

Operating gains losses

----

--15K

----

Depreciation and amortization

6.32%2.31M

10.98%2.27M

-20.39%8.62M

-25.99%2.22M

31.16%2.19M

-32.80%2.17M

-30.37%2.04M

8.97%10.82M

-9.35%3M

-25.06%1.67M

Other non cash items

-445.19%-825K

898.31%2.37M

126.90%1.22M

172.02%507K

-42.72%240K

-41.99%239K

-42.48%237K

106.53%539K

---704K

--419K

Change In working capital

960.59%16.87M

46.20%-14.33M

10.22%-42.44M

49.04%-2.55M

-587.31%-14.85M

110.69%1.59M

-5.64%-26.63M

-274.54%-47.27M

-119.18%-5.01M

37.21%-2.16M

-Change in receivables

-59.11%-2.04M

239.87%1.07M

23.97%-11.3M

-45.58%-4.91M

-162.21%-4.35M

83.80%-1.28M

60.59%-765K

-463.63%-14.86M

-27.80%-3.37M

---1.66M

-Change in inventory

35.20%-3.42M

-116.06%-3.39M

56.09%-16.15M

-5.38%-6.25M

48.34%-3.06M

54.97%-5.27M

88.13%-1.57M

-2,780.11%-36.78M

-364.06%-5.93M

---5.93M

-Change in prepaid assets

203.62%5.26M

-12.05%-2.29M

-2,345.24%-17.73M

-403.95%-3.16M

-282.98%-7.45M

-1,648.78%-5.08M

-1,288.44%-2.04M

86.05%-725K

5,095.00%1.04M

63.13%-1.95M

-Change in payables and accrued expense

9.08%10.26M

72.68%-3.13M

323.32%3.83M

766.97%7.96M

-136.35%-2.08M

559.71%9.4M

-172.64%-11.45M

-105.87%-1.72M

-105.29%-1.19M

11,777.55%5.72M

-Change in other current assets

-171.81%-298K

76.87%-96K

----

--415K

---415K

----

-Change in other current liabilities

283.21%2.23M

181.67%909K

-1,280.64%-4.82M

21.64%-1.25M

-875.00%-1.24M

-198.54%-1.22M

-282.76%-1.11M

173.38%408K

-580.12%-1.59M

149.23%160K

-Change in other working capital

5.56%4.88M

20.19%-7.4M

-41.83%3.73M

-16.33%5.05M

123.98%3.34M

-11.05%4.62M

-47.03%-9.28M

-15.06%6.41M

-15.38%6.03M

-32.62%1.49M

Cash from discontinued investing activities

Operating cash flow

0.03%-44.31M

9.34%-71.85M

-21.22%-256.81M

-50.73%-67.93M

-60.49%-65.31M

6.66%-44.32M

-0.81%-79.26M

-8.97%-211.86M

27.71%-45.07M

24.40%-40.69M

Investing cash flow

Cash flow from continuing investing activities

-858.82%-134.66M

-894.53%-222.5M

-96.18%12.11M

-138.39%-17.51M

-122.46%-16.13M

-83.68%17.75M

-69.27%28M

512.84%317.31M

121.09%45.61M

418.22%71.82M

Net PPE purchase and sale

51.39%-384K

77.70%-252K

63.07%-3.23M

76.93%-1.05M

4.41%-260K

43.33%-790K

55.23%-1.13M

-156.34%-8.75M

-105.86%-4.56M

58.15%-272K

Net investment purchase and sale

-824.41%-134.28M

-862.85%-222.25M

-95.29%15.34M

-132.80%-16.46M

-122.01%-15.87M

-83.17%18.54M

-68.89%29.13M

543.95%326.07M

119.61%50.17M

428.89%72.09M

Cash from discontinued investing activities

Investing cash flow

-858.82%-134.66M

-894.53%-222.5M

-96.18%12.11M

-138.39%-17.51M

-122.46%-16.13M

-83.68%17.75M

-69.27%28M

512.84%317.31M

121.09%45.61M

418.22%71.82M

Financing cash flow

Cash flow from continuing financing activities

16,542.81%48.6M

-10.00%1.6M

398.55%434.34M

410.52%387.17M

1,645.72%45.09M

-96.31%292K

127.04%1.78M

-70.78%87.12M

-0.66%75.84M

-53.43%2.58M

Net issuance payments of debt

----

476.38%431.12M

----

3.21%74.8M

----

Net common stock issuance

----

--46.14M

--2.07M

--44.07M

----

--0

----

Proceeds from stock option exercised by employees

-43.16%216K

-30.25%2.58M

-326.14%-39.82M

-4,549.90%-46.01M

-62.13%2.11M

-95.27%380K

24.76%3.7M

27.07%17.61M

-87.02%1.03M

243.23%5.57M

Net other financing activities

-29.55%-114K

48.99%-981K

41.12%-3.11M

-266.67%-10K

63.49%-1.09M

25.42%-88K

11.95%-1.92M

30.59%-5.29M

100.15%6K

-95.23%-2.99M

Cash from discontinued financing activities

Financing cash flow

16,542.81%48.6M

-10.00%1.6M

398.55%434.34M

410.52%387.17M

1,645.72%45.09M

-96.31%292K

127.04%1.78M

-70.78%87.12M

-0.66%75.84M

-53.43%2.58M

Net cash flow

Beginning cash position

-11.94%394.26M

38.20%687.15M

63.21%497.2M

-8.44%385.32M

8.94%421.71M

40.83%447.73M

63.21%497.2M

9.68%304.63M

55.86%420.82M

13.57%387.11M

Current changes in cash

-396.03%-130.37M

-491.75%-292.75M

-1.53%189.63M

295.03%301.73M

-207.83%-36.35M

-137.99%-26.28M

-472.31%-49.47M

616.41%192.57M

120.55%76.38M

147.58%33.71M

Effect of exchange rate changes

-215.44%-299K

---147K

--319K

--99K

---39K

--259K

--0

----

End cash Position

-37.50%263.58M

-11.94%394.26M

38.20%687.15M

-8.44%385.32M

8.94%421.71M

40.83%447.73M

63.21%497.2M

55.86%420.82M

Free cash flow

0.93%-44.69M

10.30%-72.11M

-17.87%-260.05M

-38.99%-68.98M

-60.06%-65.57M

7.70%-45.11M

0.94%-80.39M

-11.49%-220.62M

23.17%-49.63M

24.80%-40.97M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	0.03%-44.31M	9.34%-71.85M	-21.22%-256.81M	-50.73%-67.93M	-60.49%-65.31M	6.66%-44.32M	-0.81%-79.26M	-8.97%-211.86M	27.71%-45.07M	24.40%-40.69M
Net income from continuing operations	-18.51%-82.47M	-8.67%-81.42M	-22.43%-303.09M	-41.70%-87.58M	-18.55%-70.99M	-31.70%-69.59M	-2.61%-74.93M	7.20%-247.55M	35.60%-61.81M	7.23%-59.88M
Operating gains losses	----	--15K	----	----	----	----	----	----	----	----
Depreciation and amortization	6.32%2.31M	10.98%2.27M	-20.39%8.62M	-25.99%2.22M	31.16%2.19M	-32.80%2.17M	-30.37%2.04M	8.97%10.82M	-9.35%3M	-25.06%1.67M
Other non cash items	-445.19%-825K	898.31%2.37M	126.90%1.22M	172.02%507K	-42.72%240K	-41.99%239K	-42.48%237K	106.53%539K	---704K	--419K
Change In working capital	960.59%16.87M	46.20%-14.33M	10.22%-42.44M	49.04%-2.55M	-587.31%-14.85M	110.69%1.59M	-5.64%-26.63M	-274.54%-47.27M	-119.18%-5.01M	37.21%-2.16M
-Change in receivables	-59.11%-2.04M	239.87%1.07M	23.97%-11.3M	-45.58%-4.91M	-162.21%-4.35M	83.80%-1.28M	60.59%-765K	-463.63%-14.86M	-27.80%-3.37M	---1.66M
-Change in inventory	35.20%-3.42M	-116.06%-3.39M	56.09%-16.15M	-5.38%-6.25M	48.34%-3.06M	54.97%-5.27M	88.13%-1.57M	-2,780.11%-36.78M	-364.06%-5.93M	---5.93M
-Change in prepaid assets	203.62%5.26M	-12.05%-2.29M	-2,345.24%-17.73M	-403.95%-3.16M	-282.98%-7.45M	-1,648.78%-5.08M	-1,288.44%-2.04M	86.05%-725K	5,095.00%1.04M	63.13%-1.95M
-Change in payables and accrued expense	9.08%10.26M	72.68%-3.13M	323.32%3.83M	766.97%7.96M	-136.35%-2.08M	559.71%9.4M	-172.64%-11.45M	-105.87%-1.72M	-105.29%-1.19M	11,777.55%5.72M
-Change in other current assets	-171.81%-298K	76.87%-96K	----	----	----	--415K	---415K	----	----	----
-Change in other current liabilities	283.21%2.23M	181.67%909K	-1,280.64%-4.82M	21.64%-1.25M	-875.00%-1.24M	-198.54%-1.22M	-282.76%-1.11M	173.38%408K	-580.12%-1.59M	149.23%160K
-Change in other working capital	5.56%4.88M	20.19%-7.4M	-41.83%3.73M	-16.33%5.05M	123.98%3.34M	-11.05%4.62M	-47.03%-9.28M	-15.06%6.41M	-15.38%6.03M	-32.62%1.49M
Cash from discontinued investing activities
Operating cash flow	0.03%-44.31M	9.34%-71.85M	-21.22%-256.81M	-50.73%-67.93M	-60.49%-65.31M	6.66%-44.32M	-0.81%-79.26M	-8.97%-211.86M	27.71%-45.07M	24.40%-40.69M
Investing cash flow
Cash flow from continuing investing activities	-858.82%-134.66M	-894.53%-222.5M	-96.18%12.11M	-138.39%-17.51M	-122.46%-16.13M	-83.68%17.75M	-69.27%28M	512.84%317.31M	121.09%45.61M	418.22%71.82M
Net PPE purchase and sale	51.39%-384K	77.70%-252K	63.07%-3.23M	76.93%-1.05M	4.41%-260K	43.33%-790K	55.23%-1.13M	-156.34%-8.75M	-105.86%-4.56M	58.15%-272K
Net investment purchase and sale	-824.41%-134.28M	-862.85%-222.25M	-95.29%15.34M	-132.80%-16.46M	-122.01%-15.87M	-83.17%18.54M	-68.89%29.13M	543.95%326.07M	119.61%50.17M	428.89%72.09M
Cash from discontinued investing activities
Investing cash flow	-858.82%-134.66M	-894.53%-222.5M	-96.18%12.11M	-138.39%-17.51M	-122.46%-16.13M	-83.68%17.75M	-69.27%28M	512.84%317.31M	121.09%45.61M	418.22%71.82M
Financing cash flow
Cash flow from continuing financing activities	16,542.81%48.6M	-10.00%1.6M	398.55%434.34M	410.52%387.17M	1,645.72%45.09M	-96.31%292K	127.04%1.78M	-70.78%87.12M	-0.66%75.84M	-53.43%2.58M
Net issuance payments of debt	----	----	476.38%431.12M	----	----	----	----	3.21%74.8M	----	----
Net common stock issuance	----	----	--46.14M	--2.07M	--44.07M	----	----	--0	--0	----
Proceeds from stock option exercised by employees	-43.16%216K	-30.25%2.58M	-326.14%-39.82M	-4,549.90%-46.01M	-62.13%2.11M	-95.27%380K	24.76%3.7M	27.07%17.61M	-87.02%1.03M	243.23%5.57M
Net other financing activities	-29.55%-114K	48.99%-981K	41.12%-3.11M	-266.67%-10K	63.49%-1.09M	25.42%-88K	11.95%-1.92M	30.59%-5.29M	100.15%6K	-95.23%-2.99M
Cash from discontinued financing activities
Financing cash flow	16,542.81%48.6M	-10.00%1.6M	398.55%434.34M	410.52%387.17M	1,645.72%45.09M	-96.31%292K	127.04%1.78M	-70.78%87.12M	-0.66%75.84M	-53.43%2.58M
Net cash flow
Beginning cash position	-11.94%394.26M	38.20%687.15M	63.21%497.2M	-8.44%385.32M	8.94%421.71M	40.83%447.73M	63.21%497.2M	9.68%304.63M	55.86%420.82M	13.57%387.11M
Current changes in cash	-396.03%-130.37M	-491.75%-292.75M	-1.53%189.63M	295.03%301.73M	-207.83%-36.35M	-137.99%-26.28M	-472.31%-49.47M	616.41%192.57M	120.55%76.38M	147.58%33.71M
Effect of exchange rate changes	-215.44%-299K	---147K	--319K	--99K	---39K	--259K	--0	--0	--0	----
End cash Position	-37.50%263.58M	-11.94%394.26M	38.20%687.15M	38.20%687.15M	-8.44%385.32M	8.94%421.71M	40.83%447.73M	63.21%497.2M	63.21%497.2M	55.86%420.82M
Free cash flow	0.93%-44.69M	10.30%-72.11M	-17.87%-260.05M	-38.99%-68.98M	-60.06%-65.57M	7.70%-45.11M	0.94%-80.39M	-11.49%-220.62M	23.17%-49.63M	24.80%-40.97M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall